Boc-L-Tyr(Bzl)-CHN2

Boc-L-Tyr(Bzl)-CHN2 is a protected tyrosine derivative bearing a Boc-protected amino group, a benzyl-protected phenolic side chain, and a C-terminal hydrazide (CHN2) functionality. This combination is commonly used as a peptide synthesis and intermediate-building reagent where controlled reactivity at the tyrosine oxygen and a terminal hydrazide handle are required for downstream coupling, segment formation, or specialized peptide/amide construction. The L-configuration and orthogonal protection pattern support reliable handling under peptide-manufacturing conditions while preserving the reactive terminal functionality for subsequent transformations.

1. Peptide Segment Coupling

Boc-L-Tyr(Bzl)-CHN2 is used as a protected tyrosine-containing segment component in peptide synthesis workflows that require a terminal hydrazide for controlled downstream assembly. Researchers in peptide manufacturing and custom peptide synthesis often select this form when they want to introduce a tyrosine residue with a benzyl-protected phenol, minimizing side reactions during coupling steps while maintaining the terminal hydrazide functionality for later conversion into an amide or for specialized condensation strategies. The Boc protection on the amino group supports compatibility with protected-amino-acid handling and stepwise assembly, enabling reliable integration of the Tyr(Bzl) residue into larger peptide targets.

2. Tyrosine-Functionalized Intermediate Synthesis

Boc-L-Tyr(Bzl)-CHN2 serves as a practical intermediate for building tyrosine-containing amide frameworks where the benzyl-protected phenolic group must remain masked until the desired stage of synthesis. In pharmaceutical intermediate development and medicinal chemistry research, this reagent is employed to prepare defined Tyr-bearing fragments that can be further elaborated into peptide-like structures, constrained analogs, or amide-containing scaffolds. The hydrazide terminus provides a synthetically useful functional handle for converting the fragment into downstream coupling-ready forms, while the Boc and Bzl protections help maintain chemoselectivity across multi-step sequences.

3. Hydrazide-Based Amide Construction

Boc-L-Tyr(Bzl)-CHN2 is frequently chosen for workflows that use hydrazide intermediates to access amide products with precise incorporation of a protected tyrosine residue. Chemical biology and peptide chemistry groups use this reagent when the hydrazide functionality is part of a deliberate strategy to generate amide linkages under conditions compatible with the protected phenol (Bzl) and the protected amino terminus (Boc) during earlier steps. This makes the compound a useful building block for preparing defined peptide bonds or peptide-derived linkers where controlling the timing of functional group exposure is important for overall yield and purity in complex synthetic campaigns.

4. Protected Tyrosine Building Block

Boc-L-Tyr(Bzl)-CHN2 is well aligned with protected-amino-acid building block requirements for tyrosine-containing sequences, particularly when phenolic protection is necessary to prevent side-chain reactivity during assembly. Peptide synthesis teams and process development chemists value the benzyl-protected tyrosine oxygen for reducing undesired oxidation or side reactions, while the Boc-protected amino group supports standard protected-residue handling. The presence of the terminal hydrazide further distinguishes this reagent from simple protected esters or amides, enabling it to function as a more specialized intermediate in tyrosine-directed fragment construction and subsequent bond-forming steps.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle